Skip to main content Skip to section navigation Skip to footer
Our Company Pipeline Spotlight Media & Investors Contact
Bioscience
Bioscience Obesity
Nasdaq: SKYE
© 2025 Skye Bioscience.
All Rights Reserved.
Terms of Use Privacy Policy
Facebook X LinkedIn
Bioscience Obesity
Our Company Pipeline Spotlight Media & Investors Contact

News Releases

Investors

Investors

  • Overview
  • News
  • Company Info
    • Highlights
    • Corporate Presentation
    • IR Calendar/Webcasts
    • Executive Team
    • Email Alerts
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Analyst Coverage
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
Jan 12, 2015 8:00 am EST
NEMUS Bioscience Announces Appointment of Thomas A. George, CFO of Deckers Brands, to Its Board of Directors

Dec 4, 2014 1:05 pm EST
NEMUS to Move Forward With Cannabinoid-Based Therapy for Open-Angle Glaucoma

Nov 26, 2014 11:38 am EST
NEMUS Bioscience Is Now Quoted on the OTC Bulletin Board Under the Ticker Symbol of “NMUS”

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • account_treeSitemap
11250 El Camino Real, Suite 100
San Diego, CA 92130
info@skyebioscience.com
Company
Our Company Careers Investors Contact
Product
Obesity
Media
News
© 2026 Skye Bioscience.
All Rights Reserved.
Terms of use Privacy Policy
Facebook Twitter LinkedIn